HaiHe Biopharma
PrivateLast Round
Private Placement
Sep 26, 2025
Total Funding Raised
$317.6M
Company Overview
Haihe Biopharma is a biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative anti-tumor drugs, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors, aimed at enhancing health outcomes and research quality.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HaiHe Biopharma Comps
Public and private peers based on sector, stage, and business model.
HaiHe Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 26, 2025 | ||||
| Series C | Jun 1, 2023 | ||||
| Series B | Jul 24, 2020 | ||||
| Series A | Feb 11, 2019 |
HaiHe Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A, Series B |
| Hillhouse Investment | Series A |
| 招银国际金融有限公司 | Series B |
| TF Capital | Series B |
| Shanghai Science and Technology Innovation Center Equity Investment Fund | Series B |
| China International Capital Corporation | Series B |
| CAS Venture Capital | Series A |
HaiHe Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HaiHe Biopharma's valuation, stock price, and market status.
